
GRFS vs ACAD
$GRFS vs $ACAD head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
GRFS vs ACAD: the quick read
- ·GRFS is the larger company by market cap ($4.98B vs $4.70B).
- ·ACAD has been more active on our scanner (59 vs 20 alerts in 30 days).
- ·ACAD has the smaller float (169.6M vs 680.6M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Pharmaceutical Preparations vs PHARMACEUTICAL PREPARATIONS), so they answer to different catalysts and a move in one says little about the other.
- ·Both stay busy on our scanner, 59 and 20 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 6% of each other on market cap, which makes the rest of this table the interesting part.
- ·ACAD is the one in play today, trading about 3.3x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing GRFS and ACAD on TheDesperateTrader.
- Is GRFS or ACAD the better stock?
- "Better" depends on your goal, and these two are not alike. GRFS is the larger company by market cap ($4.98B vs $4.70B). ACAD has been more active on our scanner (59 vs 20 alerts in 30 days). ACAD has the smaller float (169.6M vs 680.6M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between GRFS and ACAD?
- The differences that matter: they are not in the same business - GRFS is pharmaceutical preparations and ACAD is pharmaceutical preparations; they are similar in size ($4.98B vs $4.70B); they trade at very different share prices ($7.30 vs $27.23); GRFS sits at 10% of its 52-week range against 67% for ACAD; our scanner flagged GRFS 20 times in the last 30 days against 59 for ACAD. Everything above is measured from the latest completed session and SEC filings.
- Which of GRFS and ACAD is more active right now?
- Right now GRFS is at about 0.9x its normal volume and ACAD is at about 3.3x, so ACAD is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading GRFS or ACAD? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.